Skip to main content

Selected Publications

 

Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Zhou S, Kachhap S, Sun W, Wu G, Chuang A, Poeta L, Grumbine L, Mithani SK, Chatterjee A, Koch W, Westra WH, Maitra A, Glazer C, Carducci M, Sidransky D, McFate T, Verma A, Califano JA.Proc Natl Acad Sci U S A. 2007 May 1;104(18):7540-5. doi: 10.1073/pnas.0610818104. Epub 2007 Apr 24.PMID: 17456604 

MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma. Zhao Y, Ling Z, Hao Y, Pang X, Han X, Califano JA, Shan L, Gu X.Oncotarget. 2017 Apr 11;8(15):25005-25020. doi: 10.18632/oncotarget.15334.PMID: 28212569 

Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo. Zhao Y, Hao Y, Ji H, Fang Y, Guo Y, Sha W, Zhou Y, Pang X, Southerland WM, Califano JA, Gu X.Cancer Prev Res (Phila). 2010 Jun;3(6):787-96. doi: 10.1158/1940-6207.CAPR-09-0243. Epub 2010 May 25.PMID: 20501859